Pulmonary Hypertension (PH)
The high-yield summary of Pulmonary Hypertension (PH) can be divided into five main types, each with unique causes, pathophysiology, and treatment approaches.
Pulmonary Arterial Hypertension (PAH) - Group 1:
Key Points:
- Causes: Idiopathic, heritable, drugs and toxins, associated conditions (e.g., connective tissue diseases, HIV).
- Pathophysiology: Narrowing/stiffening of pulmonary arteries, increased right heart workload.
- Treatment: Endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogs.
Pulmonary Hypertension due to Left Heart Disease - Group 2:
Key Points:
- Causes: Left ventricular dysfunction, valvular heart diseases.
- Pathophysiology: Increased left atrial pressure leads to increased pulmonary pressure.
- Treatment: Management of underlying heart disease, heart failure medications, and surgical interventions.
Pulmonary Hypertension due to Lung Diseases/Hypoxia - Group 3:
Key Points:
- Causes: COPD, interstitial lung diseases, chronic hypoxia.
- Pathophysiology: Vasoconstriction and remodeling in pulmonary arteries due to chronic lung diseases and hypoxia.
- Treatment: Management of lung conditions, oxygen therapy, pulmonary rehabilitation.
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) - Group 4:
Key Points:
- Causes: Chronic blood clots in the lungs.
- Pathophysiology: Persistent clots increase pressure in pulmonary arteries.
- Treatment: Anticoagulation therapy, pulmonary thromboendarterectomy, PH medications in some cases.
Pulmonary Hypertension due to Unknown Multifactorial Mechanisms - Group 5:
Key Points:
- Causes: Hematologic, systemic, metabolic disorders.
- Pathophysiology: Multifactorial, not well understood.
- Treatment: Manage underlying condition, symptomatic treatment for PH.
Understanding these distinctions is critical for diagnosing and managing PH in clinical practice.